balance equationreview2019-03-31
Difference 11432000 exceeds tolerance 5073071.000. Presentation or filing-vintage differences need review.
Revenue
$5.94B
Fiscal year ended 2026-03-31Operating income
$1.10B
Fiscal year ended 2026-03-31Free cash flow
$972.40M
Fiscal year ended 2026-03-31STERIS plc (STE) reported revenue of $5.94B and net income of $782.30M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from STERIS plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Income
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | $2.62B | $2.61B |
| Cost of revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B | $1.53B | $1.59B |
| Gross profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B | $1.09B | $1.03B |
| Operating income | $1.10B | $866.60M | $836.10M | $791.10M | $477.82M | $548.37M | $537.05M | $411.02M | $399.88M | $226.21M |
| Net income | $782.30M | $614.60M | $378.20M | $107.03M | $243.89M | $397.40M | $407.66M | $303.72M | $290.92M | $109.96M |
| Research & development | $112.90M | $107.60M | $103.70M | $98.48M | $86.66M | $66.33M | $65.55M | $63.04M | $60.78M | $59.40M |
| Weighted-average diluted shares | shares 98.70M | shares 99.10M | shares 99.40M | shares 100.25M | shares 98.33M | shares 85.90M | shares 85.64M | shares 85.47M | shares 85.71M | shares 86.09M |
| Pretax income | $1.05B | $796.20M | $702.80M | $680.27M | $366.80M | $517.53M | $498.75M | $369.03M | $354.98M | $184.65M |
| Income tax expense | $262.20M | $184.70M | $149.50M | $124.07M | $82.34M | $120.66M | $90.90M | $64.28M | $63.36M | $74.02M |
| Diluted EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 |
| Selling, general & administrative | $1.41B | $1.33B | $1.25B | $1.09B | $1.32B | $731.32M | $716.73M | $669.94M | $631.98M | $682.04M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $439.60M | $171.70M | $207.02M | $208.36M | $348.32M | $220.53M | $319.58M | $220.63M | $201.53M | $282.92M |
| Total assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | Unavailable |
| Current assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B | $1.21B | $1.22B | $1.05B | $989.66M | Unavailable |
| Total liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B | $2.68B | $2.02B | $1.89B | $1.98B | Unavailable |
| Current liabilities | $1.14B | $1.02B | $931.13M | $861.84M | $922.22M | $577.92M | $503.61M | $465.20M | $398.46M | Unavailable |
| Total equity incl. NCI | $7.20B | $6.62B | $6.32B | $6.09B | $6.54B | $3.89B | $3.42B | $3.20B | $3.22B | $2.81B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $631.80M | $581.30M | $674.54M | $604.41M | $575.00M | $315.07M | $263.54M | $208.24M | $205.73M | Unavailable |
| Accounts receivable | $1.09B | $1.04B | $1.01B | $864.99M | $799.04M | $609.41M | $586.48M | $564.83M | $528.07M | Unavailable |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $3.94B | $3.03B | $2.36B | $2.32B | $2.43B | $2.23B |
| Long-term debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B | $1.65B | $1.15B | $1.18B | $1.32B | Unavailable |
| Accounts payable | $338.80M | $280.80M | $251.72M | $264.16M | $225.74M | $156.95M | $149.34M | $152.91M | $135.87M | Unavailable |
Cash flow
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.34B | $1.15B | $973.30M | $756.95M | $684.81M | $689.64M | $590.56M | $539.50M | $457.63M | $424.09M |
| Capital expenditures | $369.00M | $370.10M | $360.30M | $361.97M | $287.56M | $239.26M | $214.52M | $189.72M | $165.46M | $172.90M |
| Investing cash flow | -$512.50M | $388.80M | -$887.40M | -$383.33M | -$666.56M | -$1.15B | -$319.74M | -$213.22M | -$203.83M | -$104.26M |
| Financing cash flow | -$568.20M | -$1.57B | -$85.20M | -$498.72M | $115.83M | $345.62M | -$163.15M | -$294.79M | -$356.18M | -$267.10M |
| Net change in cash | $267.90M | -$35.30M | -$1.30M | -$139.96M | $127.79M | -$99.05M | $98.95M | $19.10M | -$81.38M | $34.08M |
| Stock-based compensation | $61.70M | $57.40M | $56.50M | $38.95M | $57.66M | $25.97M | $23.81M | $23.96M | $22.19M | $18.79M |
| Common dividends paid | $241.80M | $219.90M | $200.60M | $183.50M | $163.17M | $133.84M | $123.03M | $112.50M | $102.93M | $93.19M |
| Common share repurchases | $235.50M | $211.30M | $11.80M | $308.56M | $55.78M | $14.65M | $51.24M | $81.49M | $65.48M | $97.51M |
| Depreciation & amortization | $486.50M | $476.20M | $565.20M | $552.90M | $553.10M | $219.24M | $197.24M | $225.92M | $178.33M | $188.14M |
Derived
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $972.40M | $778.00M | $613.00M | $394.98M | $397.25M | $450.38M | $376.04M | $349.79M | $292.18M | $251.18M |
| Gross margin | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% |
| Operating margin | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% | 15.3% | 8.7% |
| FCF margin | 16.4% | 14.3% | 11.9% | 8.7% | 9.4% | 14.5% | 12.4% | 12.6% | 11.2% | 9.6% |
| SBC / revenue | 1.0% | 1.1% | 1.1% | 0.9% | 1.4% | 0.8% | 0.8% | 0.9% | 0.8% | 0.7% |
| Current ratio | 2.09x | 1.96x | 3.08x | 2.33x | 2.04x | 2.10x | 2.43x | 2.27x | 2.48x | Unavailable |
| Revenue YoY growth | 8.7% | 6.2% | 13.3% | 7.4% | 35.9% | 2.5% | 8.9% | 6.2% | 0.3% | Unavailable |
| Net margin | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% |
| R&D / revenue | 1.9% | 2.0% | 2.0% | 2.2% | 2.1% | 2.1% | 2.2% | 2.3% | 2.3% | 2.3% |
| CapEx / revenue | 6.2% | 6.8% | 7.0% | 8.0% | 6.8% | 7.7% | 7.1% | 6.8% | 6.3% | 6.6% |
| Long-term debt / equity | 0.25x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 25.0% | 23.2% | 21.3% | 18.2% | 22.4% | 23.3% | 18.2% | 17.4% | 17.8% | 40.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open STE in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-K · Filed 2026-05-29View SEC filing
10-Q · Filed 2026-02-06View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-K · Filed 2025-05-29View SEC filing
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.